These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30693452)

  • 21. Proposed modification of the seventh American Joint Committee on Cancer staging system for esophageal squamous cell carcinoma in Chinese patients.
    Hou X; Wei JC; Fu JH; Wang X; Zhang LJ; Lin P; Yang HX
    Ann Surg Oncol; 2014 Jan; 21(1):337-42. PubMed ID: 24046121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracapsular lymph node involvement in esophageal cancer and number of involved nodes.
    Lerut T; Moons J; Fieuws S
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1855-6. PubMed ID: 15173764
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of surgical staging in esophageal carcinoma.
    Rausei S; Biondi A; Cananzi FC; La Greca C; Persiani R
    Rays; 2006; 31(1):47-52. PubMed ID: 16999375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of thoracoscopic lymph node staging for lung and esophageal cancer.
    Krasna MJ
    Oncology (Williston Park); 1996 Jun; 10(6):793-802; discussion 804, 813-4. PubMed ID: 8823795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An evaluation of the number of lymph nodes examined and survival for node-negative esophageal carcinoma: data from China.
    Yang HX; Xu Y; Fu JH; Wang JY; Lin P; Rong TH
    Ann Surg Oncol; 2010 Jul; 17(7):1901-11. PubMed ID: 20146101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of lymph node staging on therapy of esophageal carcinoma.
    Vazquez-Sequeiros E; Wiersema MJ; Clain JE; Norton ID; Levy MJ; Romero Y; Salomao D; Dierkhising R; Zinsmeister AR
    Gastroenterology; 2003 Dec; 125(6):1626-35. PubMed ID: 14724814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer.
    Rusch VW; Asamura H; Watanabe H; Giroux DJ; Rami-Porta R; Goldstraw P;
    J Thorac Oncol; 2009 May; 4(5):568-77. PubMed ID: 19357537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nodal staging: number or site of nodes? How to improve accuracy? Is FNA always necessary? Junctional tumors--what's N and what's M?
    Vazquez-Sequeiros E
    Endoscopy; 2006 Jun; 38 Suppl 1():S4-8. PubMed ID: 16802214
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma.
    Shao Y; Geng Y; Gu W; Ning Z; Huang J; Pei H; Jiang J
    J Thorac Oncol; 2016 Oct; 11(10):1774-84. PubMed ID: 27393473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymph node ratio-based staging system for esophageal squamous cell carcinoma.
    Chen SB; Weng HR; Wang G; Zou XF; Liu DT; Chen YP; Zhang H
    World J Gastroenterol; 2015 Jun; 21(24):7514-21. PubMed ID: 26139998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Refining the Nodal Staging for Esophageal Squamous Cell Carcinoma Based on Lymph Node Stations.
    Peng J; Wang WP; Dong T; Cai J; Ni PZ; Chen LQ
    Ann Thorac Surg; 2016 Jan; 101(1):280-6. PubMed ID: 26381757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer.
    Izbicki JR; Hosch SB; Pichlmeier U; Rehders A; Busch C; Niendorf A; Passlick B; Broelsch CE; Pantel K
    N Engl J Med; 1997 Oct; 337(17):1188-94. PubMed ID: 9337377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with RO-resected esophageal carcinoma].
    Mühlhöfer A; Kronawitter U; Zoller WG
    Z Gastroenterol; 1998 May; 36(5):479-81. PubMed ID: 9654711
    [No Abstract]   [Full Text] [Related]  

  • 34. [Strategy of lymph nodes dissection for the lower thoracic esophageal cancer without metastasis to the upper-mediastinal lymph nodes].
    Hosokawa M
    Nihon Geka Gakkai Zasshi; 1997 Sep; 98(9):751-4. PubMed ID: 9370134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PET staging of mediastinal lymph nodes in thoracic oncology.
    Broderick SR; Meyers BF
    Thorac Surg Clin; 2012 May; 22(2):161-6. PubMed ID: 22520283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modern diagnostic evaluation and preoperative staging of esophageal cancer.
    Tytgat GN
    Schweiz Med Wochenschr; 1993 May; 123(21):1088-97. PubMed ID: 8511541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph node analysis in esophageal resection: American College of Surgeons Oncology Group Z0060 trial.
    Veeramachaneni NK; Zoole JB; Decker PA; Putnam JB; Meyers BF;
    Ann Thorac Surg; 2008 Aug; 86(2):418-21; discussion 421. PubMed ID: 18640307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic variables in thoracic esophageal squamous cell carcinoma.
    Lin CS; Chang SC; Wei YH; Chou TY; Wu YC; Lin HC; Wang LS; Hsu WH
    Ann Thorac Surg; 2009 Apr; 87(4):1056-65. PubMed ID: 19324127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimally invasive staging for esophageal cancer.
    Krasna MJ
    Chest; 1997 Oct; 112(4 Suppl):191S-194S. PubMed ID: 9337286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognostic value of three different staging schemes based on pN, MLR and LODDS in patients with T3 esophageal cancer].
    Wang L; Cai L; Chen Q; Jiang YH
    Zhonghua Zhong Liu Za Zhi; 2017 Oct; 39(10):749-753. PubMed ID: 29061018
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.